WO2021109509A1 - Composition ayant une fonction d'amélioration de l'immunité et son procédé de préparation - Google Patents
Composition ayant une fonction d'amélioration de l'immunité et son procédé de préparation Download PDFInfo
- Publication number
- WO2021109509A1 WO2021109509A1 PCT/CN2020/094722 CN2020094722W WO2021109509A1 WO 2021109509 A1 WO2021109509 A1 WO 2021109509A1 CN 2020094722 W CN2020094722 W CN 2020094722W WO 2021109509 A1 WO2021109509 A1 WO 2021109509A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- parts
- ginseng
- licorice
- refrigerator
- add
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims description 22
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 30
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 29
- 235000008434 ginseng Nutrition 0.000 claims abstract description 29
- 230000036039 immunity Effects 0.000 claims abstract description 23
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 15
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 13
- 229940079593 drug Drugs 0.000 claims abstract description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 238000004806 packaging method and process Methods 0.000 claims description 30
- 244000077995 Coix lacryma jobi Species 0.000 claims description 28
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 27
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 27
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 27
- 239000012141 concentrate Substances 0.000 claims description 27
- 229940010454 licorice Drugs 0.000 claims description 27
- 239000008213 purified water Substances 0.000 claims description 26
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 25
- 241000202807 Glycyrrhiza Species 0.000 claims description 24
- 230000001954 sterilising effect Effects 0.000 claims description 24
- 238000004659 sterilization and disinfection Methods 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 22
- 239000000706 filtrate Substances 0.000 claims description 20
- 235000013305 food Nutrition 0.000 claims description 18
- 235000008599 Poria cocos Nutrition 0.000 claims description 16
- 244000197580 Poria cocos Species 0.000 claims description 16
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 15
- 239000000600 sorbitol Substances 0.000 claims description 15
- 235000010356 sorbitol Nutrition 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 13
- 239000000047 product Substances 0.000 claims description 13
- 244000241838 Lycium barbarum Species 0.000 claims description 11
- 230000036541 health Effects 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 11
- 238000011049 filling Methods 0.000 claims description 10
- 239000013049 sediment Substances 0.000 claims description 10
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 9
- 239000004386 Erythritol Substances 0.000 claims description 7
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 7
- 235000013361 beverage Nutrition 0.000 claims description 7
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 7
- 235000019414 erythritol Nutrition 0.000 claims description 7
- 229940009714 erythritol Drugs 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000004321 preservation Methods 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 6
- 239000000811 xylitol Substances 0.000 claims description 6
- 235000010447 xylitol Nutrition 0.000 claims description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 6
- 229960002675 xylitol Drugs 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 5
- -1 dissolve Substances 0.000 claims description 3
- 235000013402 health food Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229960002920 sorbitol Drugs 0.000 claims description 3
- 241000208340 Araliaceae Species 0.000 claims 7
- 244000241872 Lycium chinense Species 0.000 abstract description 17
- 241000699670 Mus sp. Species 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 3
- 206010057249 Phagocytosis Diseases 0.000 abstract description 2
- 230000007969 cellular immunity Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000005887 cellular phagocytosis Effects 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 23
- 240000005373 Panax quinquefolius Species 0.000 description 22
- 230000001953 sensory effect Effects 0.000 description 14
- 239000007788 liquid Substances 0.000 description 12
- 238000000746 purification Methods 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 235000003599 food sweetener Nutrition 0.000 description 8
- 239000003765 sweetening agent Substances 0.000 description 8
- 235000019640 taste Nutrition 0.000 description 8
- 238000000703 high-speed centrifugation Methods 0.000 description 7
- 239000012535 impurity Substances 0.000 description 7
- 210000004698 lymphocyte Anatomy 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 230000000242 pagocytic effect Effects 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000003393 splenic effect Effects 0.000 description 3
- 244000038022 Chenopodium capitatum Species 0.000 description 2
- 235000004391 Chenopodium capitatum Nutrition 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 241000026010 Dendrobium candidum Species 0.000 description 1
- 239000004267 EU approved acidity regulator Substances 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 244000182216 Mimusops elengi Species 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the invention relates to the technical fields of medicines, health products and foods, and in particular to a composition with the function of improving immunity and a preparation method thereof.
- the invention intends to provide a Chinese herbal medicine composition, a drink and a preparation method thereof, which are aimed at sub-healthy people with low immunity, have a refreshing and pleasant mouthfeel, suitable for all seasons, and have a better immunity-improving effect.
- the present invention proposes a composition with a function of improving immunity, comprising by weight: 1-12 parts of Poria cocos, 0.1-6 parts of wolfberry, 0.1-6 parts of Coix seed, 0.1-4 parts of ginseng, and 0.1-4 parts of licorice Copies.
- the composition and the raw materials used can be directly ground into powder, or it can be an extract prepared by conventional means or other forms.
- composition includes: 2-10 parts of Poria cocos, 0.5-6 parts of wolfberry, 0.5-6 parts of Coix seed, 0.2-3 parts of ginseng, and 0.2-3 parts of licorice.
- composition includes: 3-8 parts of Poria cocos, 1-5 parts of Lycium barbarum, 1-5 parts of Coix seed, 0.5-2.5 parts of ginseng, and 0.5-2.5 parts of licorice.
- composition includes: 4-8 parts of Poria cocos, 1-3 parts of wolfberry, 1-3 parts of coix seed, 0.5-2 parts of ginseng, and 0.5-2 parts of licorice.
- composition includes: 8 parts of Poria cocos, 1 part of Chinese wolfberry, 1 part of Coix seed, 1 part of ginseng, and 1 part of licorice.
- the present invention also proposes the application of any of the preceding compositions in the preparation of immunity-enhancing drugs, health products or foods.
- the present invention also proposes a medicine, health care product or food with a composition capable of improving immunity as any of the previous items, which may include acceptable excipients in the medicine, health care product or food,
- the health food or food may be selected from beverages.
- the beverage also includes one or more of white sugar, xylitol, sorbitol, and erythritol.
- sorbitol and citric acid Preferable are sorbitol and citric acid, and the ratio of sugar to acid is preferably 156:11-12.
- the present invention also provides a method for preparing a health product or food as described above, and the preparation method includes the following steps:
- the preparation method includes the following steps:
- Blending In the purification workshop, take the clarified concentrate in (2), add purified water to dilute and mix, the ratio of the clarified concentrate to purified water is 1:1 ⁇ 1:8, and then add the corrective ( Including sweeteners and acidity regulators), dissolve, mix, and stand in a refrigerator at 4°C for 12 to 72 hours.
- corrective Including sweeteners and acidity regulators
- the preparation method includes the following steps:
- Packaging sub-packaging and packaging.
- Poria, Lycium barbarum, Coix seed and licorice are all of the same medicine and food, and ginseng (artificially planted) is a new food raw material, which can be used for ordinary foods, which not only has food safety but also enhances the body's immunity.
- the beverage made by the composition of the present invention has a refreshing and pleasant taste, is suitable for all seasons, and is convenient for consumers to accept.
- Poria cocos has a sweet and flat taste, enters the heart, lungs, and spleen channels, and can be used for edema, oliguria, phlegm, palpitations, spleen deficiency, low food, loose stools, diarrhea, restlessness, palpitations, and insomnia; medlar nourishes the kidney, nourishes the liver, Improve eyesight, strengthen muscles and bones, and relieve fatigue; Coix seed can be used for edema, athlete's foot, dysuria, diarrhea of spleen deficiency, etc.; Ginseng is returned to the spleen, lung meridian, and heart meridian, which can greatly invigorate vitality; the five drugs are used in combination, complementing each other, and the obtained solid The pharmacodynamic experiment of the drink has proved that it can significantly improve the phagocytic ability of mononuclear-macrophages in mice, enhance the transformation ability of mouse spleen lymphocytes,
- a drink for improving immunity weighing raw materials according to the following weight ratio: Poria 60kg, Lycium chinense 20kg, Coix seed 20kg, Ginseng (artificially planted) 10kg, Licorice 10kg, Sorbitol 93.15kg, Citric acid 0.69kg.
- the specific preparation method is as follows:
- Sub-packaging and packaging are carried out in the outer packaging workshop, that is, to improve the immunity of the drink.
- a drink for improving immunity weighing raw materials according to the following weight ratio: Poria cocos 80 kg, wolfberry 15 kg, coix seed 15 kg, ginseng (artificial planting) 5 kg, licorice 5 kg, erythritol 93.15 kg, and citric acid 0.69 kg.
- the specific preparation method is as follows:
- Blending In the purification workshop, take the clarified concentrate from (2), add purified water, the ratio of the clarified concentrate to purified water is 1:4, mix well, then add erythritol and citric acid to blend, Dissolve, mix, and let stand in a refrigerator at 4°C for 48h.
- Sub-packaging and packaging are carried out in the outer packaging workshop, that is, to improve the immunity of the drink.
- a drink for improving immunity weighing raw materials according to the following weight ratio: Poria cocos 40 kg, wolfberry 30 kg, coix seed 30 kg, ginseng (artificially planted) 10 kg, licorice 10 kg, sorbitol 93.15 kg, and citric acid 0.39 kg.
- the specific preparation method is as follows:
- Sub-packaging and packaging are carried out in the outer packaging workshop, that is, to improve the immunity of the drink.
- a drink for improving immunity weighing raw materials according to the following weight ratio: Poria cocos 80kg, wolfberry 10kg, coix seed 10kg, ginseng (artificially planted) 10kg, licorice 10kg, xylitol 93.15kg, and citric acid 0.69kg.
- the specific preparation method is as follows:
- Sub-packaging and packaging are carried out in the outer packaging workshop, that is, to improve the immunity of the drink.
- a drink for improving immunity The raw materials are weighed according to the following weight ratio: Poria 60kg, Lycium barbarum 15kg, Coix seed 15kg, Ginseng (artificially planted) 15kg, Licorice 15kg, White sugar 93.15kg, and citric acid 0.69kg.
- the specific preparation method is as follows:
- Sub-packaging and packaging are carried out in the outer packaging workshop, that is, to improve the immunity of the drink.
- ICR mouse clean grade, 18-22g, male.
- immune group I and immunization group II were set up, and the blank group, the control group (0.16g/kg ⁇ BW, equivalent to 5 times the recommended amount of human body,), the experimental group (given the clarified concentrate prepared in Example 1 1.15 g/kg ⁇ BW (equivalent to 1g crude drug/kg ⁇ BW, 5 times the recommended amount of the human body), 10 per group; immune group I was used for the mouse lymphocyte transformation experiment, and immune group II was used for the carbon clearance experiment.
- the group and the experimental group were given intragastric administration at 1.0mL/kg ⁇ bw, and the blank group was given an equal volume of purified water once a day. After continuous administration for 30 days, various indexes were measured.
- Positive control drug Dendrobium candidum and American ginseng capsules (recommended dose 1.92g/d for human body).
- Experimental group drug the clarified concentrated liquid in Example 1 (the weight ratio of the medicinal materials to the clarified concentrated liquid is 1: 1.15).
- a cell suspension Take the spleen aseptically to prepare a cell suspension, adjust the cell concentration to 3 ⁇ 10 6 cells/mL.
- the cell suspension was added to a 24-well culture plate in two wells, 1 mL per well, 75 ⁇ L of ConA solution was added to one hole, and the other hole was used as a control, and cultured in a 5% CO 2 , 37° C. incubator for 72 hours.
- Remove 0.7mL of the supernatant add 0.7mL of RPMI1640 culture medium without calf serum, add 50 ⁇ L/well of MTT, continue to incubate for 4h, add 1mL of acidic isopropanol, and dissolve it into a 96-well culture plate.
- mice were injected with Indian ink diluted 4 times with normal saline into the tail vein, and timed immediately after ink was injected. At 2 and 10 minutes after the ink was injected, 20 ⁇ L of blood was taken from the medial canthal vein and added to 2 mL of 0.1% Na 2 CO 3 solution, and the optical density (OD) was measured at a wavelength of 600 nm. The mice were sacrificed, the liver and spleen were weighed, and the phagocytic index was calculated.
- Phagocytosis index a end weight ⁇ K 1/3 (liver weight + spleen weight)
- the present invention can significantly improve the phagocytic ability of mononuclear-macrophages in mice, and can enhance the transformation ability of mouse spleen lymphocytes, indicating that the present invention has the function of enhancing immunity.
- the drink of the present invention have a suitable taste, it is necessary to add a certain amount of sweetener, and the formation of the flavor of the drink is produced by the combination of the sweetener and the Chinese medicinal material extract, and the appropriate sweetness can cover the bitter taste of the Chinese medicinal material , Make the taste more pleasant.
- Example 1 Take the clarified concentrated liquid in Example 1, 100g each, 6 parts in total, according to the ratio of clarified concentrated liquid to purified water of 1:1, 1:2, 1:3, 1:4, 1:5 and 1:6 Dilute, mix well, and perform sensory evaluation.
- the experimental results show that when the ratio of clarified concentrated liquid to purified water is 1:4, the sensory score is the highest, the characteristic flavor is appropriate, and will not be too thick or too weak; when the ratio of clarified concentrated liquid to purified water is 1:1 to 3, the characteristic flavor Too strong, the bitterness is strong; when the ratio of clarified concentrate to purified water is 1:5-6, the characteristic flavor is too weak, and the taste is weak. Therefore, the ratio of clarified concentrate to purified water is 1:4.
- Example 1 Take the clarified concentrated solution in Example 1 and dilute it according to the ratio of clarified concentrated solution to purified water of 1:4. Take 4 portions, each 100g, and add 15.6g white sugar, xylitol, sorbitol, and erythritol. The sugar alcohol is stirred until it is completely dissolved, and the sensory evaluation is performed.
- sorbitol has the highest sensory evaluation score and the most pleasant taste.
- the sensory scores of drinks added with white sugar and xylitol are the lowest, because their sweetness is too high and the sweetness is too strong; the sensory scores of erythritol and sorbitol are similar, but the price of erythritol is higher, which is to control the cost Therefore, sorbitol was chosen as a sweetener.
- Example 1 Take the clarified concentrated solution in Example 1 and dilute it according to the ratio of clarified concentrated solution to purified water of 1:4, take 5 portions, each 1000g, first add 156g sorbitol and stir until it is completely dissolved, then add 10.0g respectively , 11.0g, 11.5g, 12.0g, 13.0g, stir until completely dissolved, and perform sensory evaluation.
- the preferred sweetener is sorbitol, and the preferred sugar-to-acid ratio is 156:11-12.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911216167.0A CN110893222A (zh) | 2019-12-02 | 2019-12-02 | 一种具有提高免疫力功能的组合物及其制备方法 |
CN201911216167.0 | 2019-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021109509A1 true WO2021109509A1 (fr) | 2021-06-10 |
Family
ID=69788679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2020/094722 WO2021109509A1 (fr) | 2019-12-02 | 2020-06-05 | Composition ayant une fonction d'amélioration de l'immunité et son procédé de préparation |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN110893222A (fr) |
WO (1) | WO2021109509A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110893222A (zh) * | 2019-12-02 | 2020-03-20 | 江苏康缘药业股份有限公司 | 一种具有提高免疫力功能的组合物及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101849596A (zh) * | 2010-02-26 | 2010-10-06 | 湖北中烟工业有限责任公司 | 一种滋养补气保健茶及制作方法 |
CN105055497A (zh) * | 2015-07-29 | 2015-11-18 | 湖北医药学院 | 一种四君子汤茶饮及其制备工艺 |
CN106729136A (zh) * | 2016-11-28 | 2017-05-31 | 武汉哈福科技有限公司 | 一种调节免疫力的功能性食品 |
CN110893222A (zh) * | 2019-12-02 | 2020-03-20 | 江苏康缘药业股份有限公司 | 一种具有提高免疫力功能的组合物及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1985985A (zh) * | 2006-12-13 | 2007-06-27 | 徐建阳 | 健脾扶正排毒养生食疗剂方及其制备方法、以及一种功能性食品 |
CN100534474C (zh) * | 2006-12-19 | 2009-09-02 | 湖南补天药业有限公司 | 一种具有增强免疫功效的组合物及其制备方法和其用途 |
CN101524493B (zh) * | 2009-03-24 | 2012-01-18 | 范永昌 | 一种多功能中药蜜丸 |
CN108713746A (zh) * | 2018-05-31 | 2018-10-30 | 南京中生生物科技有限公司 | 一种药食同源组合物及其制备方法和应用 |
CN109007514A (zh) * | 2018-08-10 | 2018-12-18 | 江苏康缘药业股份有限公司 | 一种具有提高免疫力功能的组合物及其制备方法 |
CN109077321A (zh) * | 2018-10-29 | 2018-12-25 | 吕彦辉 | 一种具有增强免疫力和抗氧化作用的组合物及其制备方法 |
-
2019
- 2019-12-02 CN CN201911216167.0A patent/CN110893222A/zh active Pending
-
2020
- 2020-06-05 WO PCT/CN2020/094722 patent/WO2021109509A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101849596A (zh) * | 2010-02-26 | 2010-10-06 | 湖北中烟工业有限责任公司 | 一种滋养补气保健茶及制作方法 |
CN105055497A (zh) * | 2015-07-29 | 2015-11-18 | 湖北医药学院 | 一种四君子汤茶饮及其制备工艺 |
CN106729136A (zh) * | 2016-11-28 | 2017-05-31 | 武汉哈福科技有限公司 | 一种调节免疫力的功能性食品 |
CN110893222A (zh) * | 2019-12-02 | 2020-03-20 | 江苏康缘药业股份有限公司 | 一种具有提高免疫力功能的组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110893222A (zh) | 2020-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106617001B (zh) | 一种季节型消脂减肥养生保健制剂 | |
CN101926483A (zh) | 杞菊明目益智保健饮料 | |
CN102038057A (zh) | 一种滋养解酒冰茶 | |
CN115777860A (zh) | 一种西红花人参颗粒饮品、其制备方法和应用 | |
US10893689B2 (en) | Solid beverage for conditioning blood stasis constitution and method for producing the same | |
WO2021109509A1 (fr) | Composition ayant une fonction d'amélioration de l'immunité et son procédé de préparation | |
KR100352445B1 (ko) | 인삼 및 생약을 포함하는 한방 스포츠음료 및 이의 제조방법 | |
CN108967622A (zh) | 一种以枸杞芽茶为主的八宝速溶茶及其制备方法 | |
CN111919982A (zh) | 天然植物解酒饮料及其制备方法 | |
KR20140101520A (ko) | 남성 성기능 개선 및 불임 치료용 약학적 조성물 | |
CN102134550A (zh) | 一种保健补酒及其制备工艺 | |
KR101614431B1 (ko) | 남성 성기능 개선 및 불임 치료용 약학적 조성물 | |
KR100376941B1 (ko) | 조혈성 녹차 및 그의 제조방법 | |
CN113546150A (zh) | 一种治疗肾脾虚弱、气血不足的中药组合物及其制备方法和应用 | |
CN107080026A (zh) | 白果黑糖姜茶饮品 | |
CN109464609A (zh) | 具有降血脂作用的组合物及其制备方法 | |
CN111888425B (zh) | 用于治疗低血压的中药制剂及其制备方法和应用 | |
AU2021101743A4 (en) | Preparation Method of Polygonatum sibiricum Tea Bag Combined with Exercise for Prevention and Adjuvant Therapy for Hyperglycemia | |
CN102973657A (zh) | 芩暴红止咳合剂及其制备方法 | |
KR20130031678A (ko) | 한약재의 추출물을 유효성분으로 포함하는 비만 예방 및 치료용 조성물 | |
CN108478706A (zh) | 一种保护心血管的组合物及其制备方法 | |
AU2020101678A4 (en) | A health care drink and preparation method thereof | |
CN103275851B (zh) | 一种平肝明目酒及其制备方法 | |
CN101283819A (zh) | 木糖醇沙棘汁饮品 | |
CN108338297A (zh) | 一种安神健脑保健饮品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20896048 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20896048 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20896048 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 13.02.2023) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20896048 Country of ref document: EP Kind code of ref document: A1 |